Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers
Clinical trial NCT00797706 · UNKNOWN
Trial details
- NCT number
- NCT00797706
- Sponsor
- Kringle Pharma Europe AB
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2010-03-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.